Browsing by Author Saura, Cristina

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 3 to 10 of 10 < previous 
Issue DateTitleAuthor(s)
23-May-2022GDF15 is an Eribulin Response Biomarker also required for Survival of DTP Breast Cancer Cells.Bellio, Chiara; Emperador, Marta; Castellano, Pol; Gris-Oliver, Albert; Canals, Francesc; Sànchez, Àlex (Sànchez Pla); Zamora, Esther; Arribas, Joaquín V. (Vicente); Saura, Cristina; Serra, Violeta; Tabernero Caturla, Josep; Littlefield, Bruce A.; Villanueva i Cardús, Josep
7-Sep-2022High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER<sup>+</sup> breast cancerPalafox Sánchez, Marta; Monserrat, Laia; Bellet Ezquerra, Meritxell; Villacampa, Gullermo; González Pérez, Abel; Oliveira, Mafalda; Brasó Maristany, Fara; Ibrahimi, Nusaibah; Kannan, Srinivasaraghavan; Mina, Leonardo; Herrera Abreu, Maria Teresa; Odena, Andreu; Sánchez Guixé, Mònica; Capelán, Marta; Azaro, Analía; Bruna, Alejandra; Rodriguez, Olga; Guzmán, Marta; Grueso, Judit; Viaplana, Cristina; Hernandez, Javier; Su, Faye; Lin, Kui; Clarke, Robert; Caldas, Carlos; Arribas, Joaquín; Michiels, Stefan; García Sanz, Alicia; Turner, Nicholas, 1951-; Prat Aparicio, Aleix; Nuciforo, Paolo; Dienstmann, Rodrigo; Verma, Chandra S; López Bigas, Núria; Scaltriti, Maurizio; Arnedos, Monica; Saura, Cristina; Serra, Violeta
28-Apr-2023HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerOlivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás
9-Jul-2021Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE StudyGil Gil, Miguel; Bellet, Meritxell; Bergamino Sirvén, Milana; Morales, Serafín; Barnadas, Agustí; Manso, Luís; Saura, Cristina; Fernández Ortega, Adela; Garcia Martinez, Elena; Martinez Jañez, Noelia; Melé, Mireia; Villagrasa, Patricia; Celiz, Pamela; Perez Martin, X.; Ciruelos, Eva; Pernas, Sònia
31-Jan-2023Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast CancerTagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar Soler, Ramón; Harbeck, Nadia; Mastro, Lucia del; Aguilar Company, Juan; Bower, Mark; Sharkey, Rachel; Pria, Alessia dalla; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martínez Vila, Clara; Matas, Marta; Miguel Rodríguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; Avanzo, Francesca d'; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J.X.; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, María; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat Aparicio, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H.; Kuderer, Nicole M.; Pinato, David J.; Cortellini, Alessio
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
7-Jul-2022Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerModi, Shaun; Jacot, William; Yamashita, Toshinari; Sohn, Joohyuk; Vidal, Maria; Tokunaga, Eriko; Tsurutani, Junji; Ueno,Naoto T.; Prat Aparicio, Aleix; Chae, Yee Soo; Lee, Keun Seok; Niikura, Naoki; Park, Yeon Hee; Xu, Binghe; Wang, Xiaojia; Gil Gil, Miguel; Li, Wei; Pierga, Jean Yves; Im, Seock-Ah; Moore, Halle C.F.; Rugo, Hope S.; Yerushalmi, Rinat; Zagouri, Flora; Gombos, Andrea; Ki, Sung Bae; Liu, Qiang; Luo, Ting; Saura, Cristina; Schmid, Peter; Sun,Tao; Gambhire, Dhiraj; Yung, Lotus; Wang, Yibin; Singh, Jasmeet; Vitazka, Patrik; Meinhardt, Gerold; Harbeck, Nadia; Camero, David A.
1-Aug-2019Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion studyBanerji, Udai; van Herpen, Carla M. L.; Saura, Cristina; Thistiethwaite, Fiona; Lord, Simon; Moreno Aguado, Víctor; Macpherson, Iain R.; Boni, Valentina; Rolfo, Christian; Vries Ege, Elisabeth G. E. de; Rottey, Sylvie; Geenen, Jill; Eskens, Ferry; Gil-Martín, Marta; Mommers, Ellen C.; Koper, Norbert P.; Aftimos, Philippe